Cargando...
Molecular markers and prediction of response to immunotherapy in non-small cell lung cancer, an update
Immunotherapy represents one of the most promising therapeutic approaches in lung cancer, however 50% of lung cancer patients will not respond to this treatment, while others will have transitory or durable responses. Because side effects may be life threatening and treatment costs remain very high,...
Guardado en:
| Publicado en: | J Thorac Dis |
|---|---|
| Autores principales: | , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
AME Publishing Company
2019
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6353739/ https://ncbi.nlm.nih.gov/pubmed/30775025 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jtd.2018.12.48 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|